Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes - Top-Institutions - MDSpire

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

  • By

  • Batool Zamani

  • Maedeh Najafizadeh

  • Atiye Jokar

  • Habibollah Rahimi

  • Hossein Motedayyen

  • January 29, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Infectious Disease
    • Hematology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Immunology
    • Infectious Disease

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Rheumatology
    • Hematology
    • Critical Care Medicine

  • #4

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Rheumatology
    • Immunology
    • Infectious Disease

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Hematology
    • Infectious Disease

Original Source(s)

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

  • by Batool Zamani, Maedeh Najafizadeh, Atiye Jokar, Habibollah Rahimi, Hossein Motedayyen

  • January 29, 2026

Related Content

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study.

Analyzing Pain and Mental Health Trends in Young Individuals with Chronic Pain Amidst the COVID-19 Pandemic